Introduction
The relative paucity of easily reproducible animal models has limited our understanding of the pathogenetic mechanisms responsible for pancreatic inflammation and fibrosis.
Male Wistar Bonn/Kobori (WBN/Kob) rats consistently and spontaneously develop chronic pancreatitis, which is accompanied by parenchymal destruction and its replacement with fibrosis, resulting in both endocrine and exocrine dysfunction (Mori et al., 1988) . We have demonstrated that acinar cell apoptosis is associated with infiltration of T cells and that tacrolimus, an immunosuppressant, attenuates the apoptosis and chronic inflammation in this model (Yamada et al., 2001) .
It is well established that T cells infiltrate into the pancreas in human chronic
pancreatitis (Okazaki et al., 2000) . We thus consider that the present model may be useful for exploring therapeutic strategies for chronic pancreatitis in human, including the autoimmune disease now recognized as a new entity (Okazaki et al., 2000) .
There is a growing body of evidence that the renin-angiotensin system (RAS) plays a crucial role in the pathophysiology of fibrosis in the heart, kidney, and liver (Kagami et al., 1994; Bataller et al., 2000; Ostrom et al., 2003) . Both angiotensin-converting enzyme (ACE) inhibitors (ACEIs) and angiotensin II (AT-II) type 1 receptor blockers (ARBs) attenuate hepatic fibrosis by suppressing activation of hepatic stellate cells and reducing their production of transforming growth factor (TGF)-ß1 in experimental animals, suggesting that AT-II and its type 1 receptor interaction may be intimately involved in hepatic fibrosis (Jonsson et al., 2001; Yoshiji et al., 2001) . Furthermore, it has been demonstrated that anti-aldosteronic drugs suppress cardiac and renal fibrosis in experimental animals, so that aldosterone, the last product of the RAS, may also be involved in fibrosis in these organs (Epstein et al., JPET #77883 6 2001; Rocha et al., 2002) .
Pancreatic stellate cells (PSC) which have some similar properties to their counterparts in liver are involved in the pathogenesis of pancreatic fibrosis in both experimental animals and humans Haber et al., 1999) . Further, the RAS is present intrinsically in the pancreas and its gene expression is elevated during acute pancreatitis and chronic pancreatic hypoxia in experimental animals, suggesting an important role of RAS in the pathogenesis of pancreatic injury (Leung et al., 2000; Chan et al., 2000) . We recently demonstrated that both lisinopril, an ACEI, and candesartan, an ARB, in drinking water attenuate pancreatic inflammation and fibrosis by suppressing induction of TGF-ß1 mRNA and blocking activation of PSC in male WBN/Kob rats (Kuno et al., 2003; Yamada et al., 2003) . However, the effective doses of ACEI and ARB observed in the previous studies are too high for the clinical use.
It is well documented that addition of ACEI to ARB and combination therapy with both drugs can either additively or synergistically exert cardio-and reno-protection JPET #77883 8 2003; Yamada et al., 2003) . The estimated doses in the single therapy groups were 2 and 1 mg/kg/day, respectively (Kuno et al., 2003; Yamada et al., 2003) . In the present experiments, lisinopril was dissolved in drinking water and candesartan was dissolved in 1:1 mix of ethanol and polyethylene glycol, warmed to 60 centigrade, and then 1 N sodium bicarbonate solution was added before being dissolved in drinking water (Yamada et al., 2003) . Untreated group was given water containing equal volume of ethanol, polyethylene glycol, and sodium bicarbonate solution without lisinopril and candesartan. Fresh solutions were given three times a week, for a total of 10 weeks, and the amount consumed was calculated. Body weights were recorded weekly. Five male Wistar rats (20-week-old) were used as non-pancreatitis controls.
Tissue Sampling
All WBN/Kob rats treated for 10 weeks were killed with an overdose of pentobarbital sodium (Abbott Laboratories, North Chicago, IL, USA) after taking blood from the abdominal aorta. Each pancreas was immediately removed and samples were stored at -80 centigrade for determination of myeloperoxidase (MPO) activity and hydroxyproline content, or in liquid nitrogen for eventual determination of cytokine and growth factors mRNA levels by reverse transcription-polymerase chain reaction (RT-PCR). Tissue was also fixed in 10% buffered formalin for histological assessment and immunohistochemistry. Serum and plasma containing ethylenediamine tetraacetic acid sodium were kept at -80 centigrade for eventual determination of ACE (serum),
AT-II (plasma), and aldoseterone (serum). In addition, pancreases from 20-week-old
Wistar rats were immediately placed in liquid nitrogen for RT-PCR analyses.
Histologic Analyses
Pancreas tissues, obtained from both duodenal and splenic lobes, were fixed with 10% buffered formalin and routinely processed for embedding in paraffin, sectioned and stained with hematoxylin-eosin and Azan. Histologic observation was performed using a microscope having the object lens of x10, intermittent lens of x4, and eyepiece lens of x10 (Olympus BH-2, Olympus Co., Tokyo, Japan). The histologic status of inflammation in each animal was evaluated by a pathologist who was unaware of the groups, with reference to the grades of inflammatory cell infiltration, interstitial edema, acinar cell necrosis, hemorrhage, and fibrosis, as reported previously (Yamada et al., 2001; Kuno et al., 2003; Yamada et al., 2003) . Each factor was graded as none, mild, moderate, and severe, scored as 0, 1, 2 and 3, respectively. Quantity of fibrosis was analyzed under the microscope (Olympus BH-2, Olympus Co., Tokyo, Japan) connected with the 3CCD Color Video Camera (DXC-950, Sony Co., Tokyo, Japan)
with the aid of an image processor (Image Processor for Analytical Pathology; Sumica Technoservise, Osaka, Japan). The percentage of aniline-blue positive fibrous tissue per total area in whole Azan-stained pancreas section was measured except lymph nodes and major vessels, if included (Kuno et al., 2003; Yamada et al., 2003) . The results were then used to calculate values relative to the control cases, set at 100%.
Immunohistochemistry for α-Smooth Muscle Actin
Tissues were stained with mouse anti-human α-smooth muscle actin (SMA) mAb (Dako, Carpiteria, CA) which can detect rat α-SMA as described previously (Kuno et al., 2003; Yamada et al., 2003) . The relative area of α-SMA-positive cells per total area was also evaluated as described for "Histologic Analyses".
Measurement of Pancreatic Myeloperoxidase Activity
Pancreatic MPO activity, an indirect quantitative index of granulocyte infiltration, was determined as described previously (Yamada et al., 2001; Kuno et al., 2003; Yamada et al., 2003) . MPO activity was determined by measuring H2O2-dependent oxidation of 3,3',5,5' tetramethylbenzidine and expressed as units per gram wet weight of pancreas.
Measurement of Pancreatic Hydroxyproline Content
Hydroxyproline content, an indicator of collagen deposition, was determined as reported previously (Kuno et al., 2003; Yamada et al., 2003) . Hydroxyproline levels were calculated using a standard curve made with 4-hydroxy-1-proline and expressed as micrograms per gram tissue.
Measurement of Serum Angiotensin-Converting Enzyme Activity, Plasma
Angiotensin II Levels, and Serum Aldosterone Levels Serum ACE activity was determined by using a commercially available kit, ACE color (Fujirebio Co., Tokyo, Japan), and expressed as IU/L.
AT-II in the plasma containing ethylenediamine tetraacetic acid sodium was determined by radioimmunoassay as reported previously (Iwahana et al., 1996) .
Briefly, plasma was incubated with a rabbit anti-AT-II antibody and 125 I-labelled AT-II and then a goat antibody for rabbit immunoglobulin. After adding polyethylene glycol, the radioactivity of the pellet was measured using a counter. The amount of AT-II was calculated using a standard curve generated using angiotensin II human.
Serum aldosterone was determined with a commercially available aldosterone Sequences of primers for TNF-α, PDGF-B, PDGF-Rß, TGF-ß1, and ß-actin were listed in Table 1 . PCR products were electrophoresed on 1% agarose gels, visualized by ethidium bromide staining and photographed under ultraviolet light.
The relative expression intensity of each mRNA band was determined with an image analyzer (NIH image) and semiquantitative analyses relative to ß-actin were preformed.
Statistics
Data are expressed as arithmetic means ± standard deviations. Statistical JPET #77883 12 differences among groups were identified using the one-way analysis of variance, followed by multiple comparisons using the least significance difference method. The
Mann-Whitney's U-test was employed for statistical analyses of the histologic scores, relative fibrosis area, and relative area of α-SMA positive cells.
Results

Doses of Lisinopril and Candesartan, Body Weights, and Pancreas Weights
The average doses of lisinopril and candesartan in the single therapy groups calculated from water consumption and body weights were 2.34 ± 0.18 and 0.94 ± 0.05 mg/kg/day, respectively, during the experimental period. Those of lisinopril and candesartan in the combination group were 2.40 ± 0.07 and 1.26 ± 0.04 mg/kg/day, respectively. Body weights were significantly lower in the lisinopril and combination groups compared with the untreated group ( Table 2 ). The pancreas weights were significantly higher in the combination group than in the other groups.
Macroscopic Findings
The pancreases in the untreated, lisinopril, and candesartan groups had widespread brown and red foci (Fig. 1A , 1B, and 1C, respectively). In sharp contrast, the pancreases in the combination group had almost intact appearances ( Fig. 1D ) as observed in the pancreas in Wistar rat (figure not shown).
Histologic Analyses
Focal severe inflammation in the pancreas was evident in the untreated group ( Fig. 2A ). This was characterized by neutrophil and lymphocyte infiltration, interstitial edema, hemorrhage, and occasional acinar cell necrosis. Fibrosis was noted as replacing acini, being also found between remaining acini. Neither lisinopril nor candesartan had any significant effects on these inflammatory changes ( Fig. 2B and 2C ).
However, the combination therapy dramatically reduced the inflammatory changes, resulting in limited foci of lymphocyte infiltration with slight fibrosis (Fig. 2D ). No histologic alteration in the pancreas was present in Wistar rat (Fig. 2E ). Significant reduction of inflammatory scores was observed for almost all parameters in the combination group compared with the untreated, lisinopril, and candesartan groups (Table 3) . Relative fibrosis area calculated by Azan stained area in the pancreas tended to be decreased to 56.8 ± 35.4 % in the combination group compared with 100% set for the untreated group. (Table 3) .
Immunohistochemistry for α-Smooth
Pancreatic Myeloperoxidase Activity
Pancreatic MPO activity, an indirect index of granulocyte infiltration, was significantly suppressed in the combination group compared with the untreated, lisinopril, and candesartan groups (Table 2) .
Pancreatic Hydroxyproline Content
The combination therapy significantly suppressed the increase in pancreatic hydroxyproline content, an indeirect index of collagen deposition, compared with the untreated, lisinopril, and candesartan groups (Table 2) .
Serum Angiotensin-Converting Enzyme Activity, Plasma Angiotensin II Levels, and Serum Aldosterone Levels
Serum ACE activity and plasma AT-II levels were significantly decreased in the lisinopril and combination groups compared with the untreated and candesartan groups, respectively. Serum aldosterone levels were not significantly decreased in the combination group compared with the other groups ( Table 4) .
Expression of Tumor Necrosis Factor-α, Platelet-Derived Growth Factor B,
Platelet-Derived Growth Factor-Receptor ß, and Transforming Growth Factor-ß1 mRNA RT-PCR revealed TNF-α, PDGF-R ß, and TGF-ß1 mRNA to be overexpressed in the pancreas in the untreated group, while they were detected at only low levels in male Wistar rats (Fig. 3) . However, PDGF B mRNA was not upregulated in the untreated groups compared with male Wistar rats. While lisinopril and candesartan alone did not alter TNF-α, PDGF-R ß, and TGF-ß1 mRNA levels, the combination therapy suppressed upregulation of all three mRNAs. Semiquantitative analysis of each mRNA relative to ß-actin revealed that TNF-α, PDGF-R ß, and TGF-ß1 mRNA were significantly upregulated in the untreated group compared with Wistar rats and they were suppressed in the combination group (Table 5) .
Doses of Lisinopril and Candesartan, Body Weights, and Pancreas Weights in the Dose-dependence Study
Next, the dose-dependent effects of the combination therapy were assessed.
The average doses of lisinopril in the low and medium combination and combination groups were 0.29 ± 0.01, 0.62 ± 0.06, and 2.27 ± 0.12 mg/kg/day, respectively. Those of candesartan were 0.41 ± 0.01, 0.87 ± 0.08, and 1.19 ± 0.06 mg/kg/day, respectively.
The body weights were significantly lower in all three combination groups than in the untreated group, and the pancreas weights were significantly higher (Table 6 ).
Dose-dependence of the Combination Therapy Effects on Histologic Findings
In line with earlier studies, untreated animals showed severe inflammation and fibrosis in the pancreas (Fig. 4A ). Limited foci of severe and moderate focal inflammation remained in the low and medium combination groups, respectively ( Fig.   4B and 4C), so that protective effects assessed by histologic scores were observed with regard to acinar cell necrosis in the low combination group and acinar cell necrosis and fibrosis in the medium combination group, respectively (Table 7) . In contrast, significant reduction was noted for all histologic scores in the combination group ( Fig.   4D and Table 7 ).
Dose-dependence of the Combination Therapy Effects on Pancreatic Myeloperoxidase Activity and Pancreatic Hydroxyproline Content
Pancreatic MPO activity and pancreatic hydroxyproline content were significantly decreased in the three combination groups as compared with the untreated group (Table 6) .
Discussion
The We recently reported that lisinopril, an ACEI, and candesartan, an ARB, in drinking water suppress pancreatic inflammation and fibrosis in the present model (Kuno et al., 2003; Yamada et al., 2003) . However, the doses were much higher than the maximal clinical doses (lisinopril; 21.3 mg/kg/day, 65-fold and candesartan; 13.9 mg/kg/day, 70-fold). Since ACEI and ARB suppress the RAS by pharmacologically different mechanisms, the combination therapy with ACEI and ARB might be expected to be safer and more effective in inhibiting AT-II function than single therapy with twice doses of either agent. It was well documented that the combination therapy with ACEI and ARB has advantages over either therapy alone at low doses for treating heart and kidney diseases in the experimental models and humans (McKelvie et al., 1999; Mogensen et al., 2000; Rossing et al., 2003; Nakamura et al., 2003) . These findings prompted us to explore the effect of the combination therapy on chronic pancreatitis.
Since the single therapies with more than twice of the present single doses were reported to be ineffective for treating chronic pancreatitis ( Since both lisinopril and candesartan are widely used as antihypertensive drugs in human, one might speculate that they may decrease blood pressure in the present model. However, the combination therapy with much higher doses of ACEI and ARB did not cause significant decrease in blood pressure in rats with myocardial infarction (Nakamura et al., 2003) . It has been well documented that the combination therapy with ACEI and ARB did not cause excessive decrease in blood pressure in human (McKelvie et al., 1999; Mogensen et al., 2000; Rossing et al., 2003) . Taken together, it was speculated that the combination therapy may not cause excessive decrease in blood pressure in the present study.
TNF-α, a proinflammatory cytokine, is expressed in acinar cells and infiltrating macrophages in acute pancreatitis (Gukovskaya et al., 1997) . It is reported that TNF-α released from acinar cells is involved in the development of pancreatitis by mediating early inflammatory reactions (Gukovskaya et al., 1997; Xie et al., 2001a) . Its inhibition reduces acute pancreatic damage and improves survival with acute pancreatitis in rats (Hughes et al., 1996) . Moreover, tissue expression of TNF-α is involved in the onset of chronic pancreatitis in the present model (Xie et al., 2001b ).
Thus, we assessed tissue TNF-α mRNA levels and confirmed upregulation in the untreated group. Only combination therapy suppressed this.
PDGF, a dimerised protein secreted by infiltrated inflammatory cells, including macrophages and platelets, induces proliferation of PSC Luttenberger et al., 2000) . It consists of two polypeptide chains linked via disulphide bonds and has three isoforms, PDGF-A, PDGF-B, and PDGF-AB, PDGF-B having the most potent effects in vitro . The PDGF receptor is composed of two types α and ß which recognize all three types of PDGF and PDGF-B, respectively. PDGF-B
and PDGF-R ß, but not PDGF-R α, are closely associated with fibrosis in human and experimental pancreatitis (Ebert et al., 1998; Haber et al., 1999) . Furthermore, PDGF-B mRNA is upregulated in dibutyltin dichloride-induced chronic pancreatitis (Inoue et al., 2002) . We here found PDGF-R ß mRNA to be upregulated in the present model, while PDGF-B mRNA was unchanged. Again, only combination therapy suppressed this upregulation of PDGF-R ß mRNA.
It is well established that TGF-ß1, a multifunctional cytokine, mediates fibrosis in various organs (Waltenberger et al., 1993; Yoshioka et al., 1993; Bedossa et al., 1995) and TGF-ß1 precursors and its latent binding protein are observed in inflamed lesions with fibrosis in human chronic pancreatitis (Van Laethem et al., 1995) . TGF-ß1
promotes pancreatic fibrosis and inhibition of its expression results in reduction of extracellular matrix protein in experimental animals (Van Laethem et al., 1996; Menke et al., 1997) . As reported previously, TGF-ß1 mRNA was here found to be upregulated and the combination therapy suppressed this.
AT-II directly induces proliferation of pancreatic stellate cells as well as digestive enzyme secretion by acinar cells in vitro, both of which were abolished in the presence of ARBs (Reiner et al., 2004; Hama et al., 2004; Tsang et al., 2004) . We speculate that inhibition of AT-II by the combination therapy may have similar effects in the present model. Moreover, AT-II is a potent vasoconstrictor and ACEIs increase vasodilatory factors, including bradykinin, nitric oxide, and prostaglandin (Campbell et al., 1994) . The combination therapy could thus increase pancreatic blood flow by both blocking AT-II function and increasing vasodilatory factors, thereby improving pancreatic ischemia, which was reported to be one element in the pathogenesis of chronic pancreatitis (Mori et al., 1988) . Moreover, interaction between AT-II and its type 1 receptor may result in secretion of aldosterone, which may be involved in cardiac and renal fibrosis in the experimental animals (Epstein et al., 2001; Rocha et al., 2002) .
In fact, combination therapy with an ACEI and an ARB resulted in greater decrease in circulating aldosterone levels than the either agent alone in the RESOLVD study (McKelvie et al., 1999) . To our knowledge, no reports are available regarding the role JPET #77883 21 of aldosterone in chronic pancreatitis. We hypothesized that protection might be related to its decrease, but contrary to expectation, the combination therapy did not cause further depress of serum aldosterone levels compared with single lisinopril therapy, suggesting that aldosterone may not be involved in the pathogenesis of pancreatic fibrosis.
There are sporadic reports demonstrating that ACEIs caused acute pancreatitis in human (Madsen JS et al., 1995 , Muchnick et al., 1999 . Although we were able to reduce the effective dose of lisinopril by combined administration with candesartan, caution may be necessary when lisinopril is used for treating chronic pancreatitis in human.
In conclusion, the combination therapy with lisinopril and candesartan may synergistically alleviate chronic pancreatic inflammation and fibrosis in male WBN/Kob rats by suppressing upregulation of TNF-α, PDGF-R ß, and TGF-ß1 mRNA, resulting in the prevention of pancreatic stellate cell activation and pancreatic fibrosis. We propose that combination therapy with an ACEI and an ARB may allow reduction of effective doses so that treatment of chronic pancreatitis with such agents will become possible. Further studies in this area are clearly warranted. Figure   Figure 1 Gross appearance of pancreas tissue in the (A) untreated, (B) lisinopril, (C) candesartan, and (D) combination groups.
Legends for
(A), (B), and (C) Note the scattered brown and dark red foci.
(D) The pancreas has an intact appearance.
Figure 2
Representative histologic appearance of pancreas tissue in the (A) untreated, (B)
lisinopril, (C) candesartan, (D) combination groups, and (E) Wistar rat (H&E staining.
the object lens of x10, intermittent lens of x4, and eyepiece lens of x10). Scale bar in the figure 2E indicates 100 µm.
(A) Massive infiltration of neutrophils, lymphocytes, and plasma cells, with disappearance of acinar cells and replacement with fibrous tissue are evident. This sample was scored 1 for hemorrhage, 2 for inflammatory cell infiltration, interstitial edema, and acinar cell necrosis, and 3 for fibrosis.
(B)(C) Severe inflammatory changes observed in the lisinopril and candesartan groups.
(B) was scored 2 for all histologic parameters and (C) was scored 1 for acinar cell necrosis and 2 for inflammatory cell infiltration, interstitial edema, hemorrhage, and fibrosis.
(D) Focal lymphocyte infiltration with slight bleeding is observed in the combination group. This sample was scored 1 for interstitial edema, acinar cell necrosis, and fibrosis and 2 for inflammatory cell infiltration and hemorrhage.
(E) No alteration is observed.
Figure 3
Expression of TNF-α, PDGF-B, PDGF-R ß, and TGF-ß1 mRNAs analyzed by RT-PCR.
Findings are for untreated, lisinopril, candesartan, and combination groups and 20-week-old male Wistar rats. The ß-actin is included in each pancreas tissue as an internal control.
Figure 4
Representative histologic appearance of the pancreas tissue in the (A) untreated, (B) low combination, (C) medium combination, and (D) combination groups (H&E staining. the object lens of x10, intermittent lens of x4, and eyepiece lens of x10). Scale bar in the figure 4D indicates 100 µm.
(A) Severe inflammation is apparent, with lymphocyte infiltration, disappearance of acini, bleeding, and replacement with fibrous tissue. This sample was scored 2 for infiltration of inflammatory cells, interstitial edema, acinar cell necrosis, and hemorrhage, and 3 for fibrosis.
(B) Severe inflammation, characterized by lymphocyte infiltration, bleeding, and fibrosis is focally observed. This sample was scored 1 for acinar cell necrosis, 2 for infiltration of inflammatory cells, interstitial edema, and hemorrhage, and 3 for fibrosis. NOTE. Statistical analyses were performed with one-way analysis of variance, followed by multiple comparisons using the least significance difference method. NOTE. Statistical analyses were performed with one-way analysis of variance, followed by multiple comparisons using the least significance difference method. 
